Structures by: Stahly G. P.
Total: 10
Theophylline:salicylic acid cocrystal (1:1)
C7H9N4O2,C7H6O3
Molecular Pharmaceutics (2007) 4, 3 323
a=6.9183(3)Å b=25.9086(10)Å c=7.9749(4)Å
α=90.00° β=104.754(3)° γ=90.00°
Niflumic acid:maleic acid salt (1:1)
C13H10N2O2F3,C4H3O4
Molecular Pharmaceutics (2007) 4, 3 323
a=8.1434(5)Å b=20.7559(11)Å c=10.6511(7)Å
α=90.00° β=110.276(3)° γ=90.00°
Theophylline:4-hydroxybenzoic acid cocrystal (1:1)
C7H8N4O2,C7H6O3
Molecular Pharmaceutics (2007) 4, 3 323
a=7.1201(18)Å b=7.928(2)Å c=24.763(6)Å
α=90.00° β=91.660(7)° γ=90.00°
Theophylline:1-hydroxy-2-naphthoic acid cocrystal (1:1)
C7H8N4O2,C11H8O3
Molecular Pharmaceutics (2007) 4, 3 323
a=11.814(3)Å b=31.707(8)Å c=8.920(2)Å
α=90.00° β=98.072(7)° γ=90.00°
Theophylline:sorbic acid cocrystal (1:1)
C7H8N4O2,C6H8O2
Molecular Pharmaceutics (2007) 4, 3 323
a=8.7478(2)Å b=6.53610(10)Å c=12.5842(2)Å
α=90.00° β=107.2960(10)° γ=90.00°
Theophylline:acetaminophen cocrystal (1:1)
C7H8N4O2,C8H9NO2
Molecular Pharmaceutics (2007) 4, 3 323
a=8.7337(2)Å b=15.3838(3)Å c=11.5271(3)Å
α=90.00° β=99.256(2)° γ=90.00°
Anhydrous aminophylline
C7H7N4O2,0.5(C2H10N2)
Molecular Pharmaceutics (2007) 4, 3 323
a=8.7804(5)Å b=6.5989(4)Å c=16.0041(10)Å
α=90.00° β=102.292(4)° γ=90.00°
Aminophylline hydrate
2(C7H7N4O2),0.5(C2H10N2),0.5(C2H10N2),H2O
Molecular Pharmaceutics (2007) 4, 3 323
a=8.3936(7)Å b=10.2277(6)Å c=11.8295(6)Å
α=78.839(3)° β=77.795(4)° γ=81.075(4)°
Metformin HCl form I
C4H12ClN5
Crystal Growth & Design (2004) 4, 3 441
a=7.9231(12)Å b=13.894(2)Å c=7.9231(12)Å
α=90.00° β=114.48° γ=90.00°
Metformin HCl form II
C4H12ClN5
Crystal Growth & Design (2004) 4, 3 441
a=7.6261(7)Å b=6.1684(6)Å c=18.1508(16)Å
α=90.00° β=99.447(2)° γ=90.00°